1.

Record Nr.

UNISALENTO991004381534807536

Autore

Nooteboom, Cees

Titolo

La storia seguente / Cees Nooteboom ; traduzione di Fulvio Ferrari

Pubbl/distr/stampa

Milano : Feltrinelli, 1993

Titolo uniforme

Het volgende Verhall 4378566

ISBN

8807014548

Descrizione fisica

116 p. ; 20 cm

Collana

I narratori

Altri autori (Persone)

Ferrari, Fulvio

Disciplina

839.3

Lingua di pubblicazione

Italiano

Formato

Materiale a stampa

Livello bibliografico

Monografia

2.

Record Nr.

UNINA9910957217103321

Titolo

Informing America's policy on illegal drugs : what we don't know keeps hurting us / / Committee on Data and Research for Policy on Illegal Drugs ; Charles F. Manski, John V. Pepper, and Carol V. Petrie, editors

Pubbl/distr/stampa

Washington, D.C., : National Academy Press, c2001

ISBN

9786610185191

9780309171335

0309171334

9781280185199

1280185198

9780309512350

0309512352

Edizione

[1st ed.]

Descrizione fisica

1 online resource (423 p.)

Altri autori (Persone)

ManskiCharles F

PepperJohn <1964->

PetrieCarol

Disciplina

363.45/0973

Soggetti

Drug control - United States - Evaluation

Drug traffic - Research - United States

Drug abuse - Research - United States

Drug abuse - United States - Prevention - Evaluation



Evaluation research (Social action programs) - United States

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

"Committee on Law and Justice and Committee on National Statistics, Commission on Behavioral and Social Sciences and Education, National Research Council."

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Front Matter -- Contents -- Preface -- Executive Summary -- Part I Introduction and Background -- 1 Introduction -- 2 Determinants and Consequences of Drug Use -- Part II Data for Monitoring the Nation's Drug Problems -- 3 Data Needs for Monitoring Drug Problems -- 4 Drug Data Organization -- Part III Research for Drug Policy -- 5 Supply-Reduction Policy -- 6 Sanctions Against Users of Illegal Drugs -- 7 Preventing Drug Use -- 8 Treatment of Drug Users -- 9 Final Thoughts: Unfinished Business -- Appendix A Characteristics of STRIDE Cocaine Data -- Appendix B Data Sources -- Appendix C Phase I Report Executive Summary -- Appendix D How Do Response Problems Affect Survey Measurement of Trends in Drug Use? -- Appendix E Linking Treatment to Punishment: An Evaluation of Drug Treatment in the Criminal Justice System -- Appendix F Biographical Sketches -- Index.

Sommario/riassunto

How should the war on drugs be fought? Everyone seems to agree that the United States ought to use a combination of several different approaches to combat the destructive effects of illegal drug use. Yet there is a remarkable paucity of data and research information that policy makers require if they are to create a useful, realistic policy package-details about drug use, drug market economics, and perhaps most importantly the impact of drug enforcement activities.  Informing America's Policy on Illegal Drugs recommends ways to close these gaps in our understanding-by obtaining the necessary data on drug prices and consumption (quantity in addition to frequency); upgrading federal management of drug statistics; and improving our evaluation of prevention, interdiction, enforcement, and treatment efforts.  The committee reviews what we do and do not know about illegal drugs and how data are assembled and used by federal agencies. The book explores the data and research information needed to support strong drug policy analysis, describes the best methods to use, explains how to avoid misleading conclusions, and outlines strategies for increasing access to data. Informing America's Policy on Illegal Drugs also discusses how researchers can incorporate randomization into studies of drug treatment and how state and local agencies can compare alternative approaches to drug enforcement.  Charting a course toward a better-informed illegal drugs policy, this book will be important to federal and state policy makers, regulators, researchers, program administrators, enforcement officials, journalists, and advocates concerned about illegal drug use.